Windlas Biotech Limited (BOM:543329)
India · Delayed Price · Currency is INR 882.00
-1.10 (-0.12%)
At close: Apr 22, 2026
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 18.51 billion as of April 22, 2026. Its market cap has decreased by -14.87% in one year.
Market Cap
18.51B
Enterprise Value
16.22B
Revenue
8.68B
Ranking
n/a
PE Ratio
27.74
Stock Price
882.00
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 18.51B, an increase of 108.63%. That is a compound annual growth rate of 17.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 18.51B | 11.10% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 27.33B |
| Novartis India | 24.59B |
| Unichem Laboratories | 24.29B |
| Hikal | 23.28B |
| Morepen Laboratories | 22.66B |
| Kwality Pharmaceuticals | 17.27B |
| Amrutanjan Health Care | 15.70B |
| Shukra Pharmaceuticals | 15.28B |